- Published at
- by manilatimes.net
neutral
neutral
News for Locust Walk Acquisition Corp. (LWAC)
- Published at
- by globenewswire.com
mixedmixedeFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Zotatifin continued to demonstrate favorable activity and tolerability, including two previously reported confirmed partial responses (PRs) among seven...- Published at
- by etfdailynews.com
mixedmixedStock Analysts’ Upgrades for June 3rd (AI, ATNM, AXL, BANF, BPOP, CHUY, DLTH, EFTR, EONGY, ESEA)
Read Stock Analysts’ Upgrades for June 3rd (AI, ATNM, AXL, BANF, BPOP, CHUY, DLTH, EFTR, EONGY, ESEA) at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveeFFECTOR Therapeutics (NASDAQ:EFTR) Upgraded by Zacks Investment Research to “Buy”
Read eFFECTOR Therapeutics (NASDAQ:EFTR) Upgraded by Zacks Investment Research to “Buy” at ETF Daily News- Published at
- by etfdailynews.com
mixedmixedAnalysts’ Downgrades for June 2nd (AC, CCMP, CMCSA, CWBR, DINO, DIS, EFTR, EQT, ETN, ETON)
Read Analysts’ Downgrades for June 2nd (AC, CCMP, CMCSA, CWBR, DINO, DIS, EFTR, EQT, ETN, ETON) at ETF Daily News- Published at
- by etfdailynews.com
mixedmixedeFFECTOR Therapeutics (NASDAQ:EFTR) Downgraded to Hold at Zacks Investment Research
Read eFFECTOR Therapeutics (NASDAQ:EFTR) Downgraded to Hold at Zacks Investment Research at ETF Daily News- Published at
- by etfdailynews.com
mixedmixedeFFECTOR Therapeutics (NASDAQ:EFTR) Upgraded to “Buy” by Zacks Investment Research
Read eFFECTOR Therapeutics (NASDAQ:EFTR) Upgraded to “Buy” by Zacks Investment Research at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveeFFECTOR Therapeutics (NASDAQ:EFTR) Earns Buy Rating from JMP Securities
Read eFFECTOR Therapeutics (NASDAQ:EFTR) Earns Buy Rating from JMP Securities at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveeFFECTOR Therapeutics (NASDAQ:EFTR) Announces Earnings Results, Beats Estimates By $0.68 EPS
Read eFFECTOR Therapeutics (NASDAQ:EFTR) Announces Earnings Results, Beats Estimates By $0.68 EPS at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveBrokerages Set eFFECTOR Therapeutics Inc (NASDAQ:EFTR) PT at $20.04
Read Brokerages Set eFFECTOR Therapeutics Inc (NASDAQ:EFTR) PT at $20.04 at ETF Daily News